Cargando…

BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia

Oncogene inactivation in both clinical targeted therapies and conditional transgenic mouse cancer models can induce significant tumor regression associated with the robust induction of apoptosis. Here we report that in MYC-, RAS-, and BCR-ABL-induced acute lymphoblastic leukemia (ALL), apoptosis upo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yulin, Deutzmann, Anja, Choi, Peter S., Fan, Alice C., Felsher, Dean W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Priority Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053622/ https://www.ncbi.nlm.nih.gov/pubmed/27095570 http://dx.doi.org/10.18632/oncotarget.8731

Ejemplares similares

BIM-mediated apoptosis and oncogene addiction
por: Li, Yulin, et al.
Publicado: (2016)

p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia
por: Yetil, Alper, et al.
Publicado: (2015)

Regulation of Bim in Health and Disease
por: Sionov, Ronit Vogt, et al.
Publicado: (2015)

Mebendazole for Differentiation Therapy of Acute Myeloid Leukemia Identified by a Lineage Maturation Index
por: Li, Yulin, et al.
Publicado: (2019)

HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice
por: Esser, Alison K., et al.
Publicado: (2017)

Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia
por: Yadav, Babasaheb D., et al.
Publicado: (2016)

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia
por: Cerny-Reiterer, Sabine, et al.
Publicado: (2014)

Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model
por: Hasan, Md. Nabiul, et al.
Publicado: (2014)

Oncogene addiction: resetting the safety switch?
por: Li, Yulin, et al.
Publicado: (2014)

Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS
por: Tavallai, Mehrad, et al.
Publicado: (2016)

Oncogene withdrawal engages the immune system to induce sustained cancer regression
por: Casey, Stephanie C, et al.
Publicado: (2014)

Inhibition of the NEDD8 conjugation pathway induces calcium-dependent compensatory activation of the pro-survival MEK/ERK pathway in acute lymphoblastic leukemia
por: Zheng, Shuhua, et al.
Publicado: (2017)

PBRM1 Inactivation Promotes Upregulation of Human Endogenous Retroviruses in a HIF-Dependent Manner
por: Zhou, Mi, et al.
Publicado: (2022)

An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8(+) T-cell responses
por: Bruns, Michael, et al.
Publicado: (2015)

MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer
por: Menezes, Mitchell E., et al.
Publicado: (2015)

Troponin-I enhances and is required for oncogenic overgrowth
por: Casas-Tintó, Sergio, et al.
Publicado: (2016)

A mathematical model of tumor regression and recurrence after therapeutic oncogene inactivation
por: Hori, Sharon S., et al.
Publicado: (2021)

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)
por: Dhanasekaran, Renumathy, et al.
Publicado: (2017)

Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)

The impact of the MYB-NFIB fusion proto-oncogene in vivo
por: Mikse, Oliver R., et al.
Publicado: (2016)

MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC
por: Dhanasekaran, Renumathy, et al.
Publicado: (2020)

EGFR-targeted therapy results in dramatic early lung tumor regression accompanied by imaging response and immune infiltration in EGFR mutant transgenic mouse models
por: Venugopalan, Abhilash, et al.
Publicado: (2016)

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential
por: Raffeiner, Philipp, et al.
Publicado: (2014)

ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts
por: Valletta, Simona, et al.
Publicado: (2015)

Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia
por: Reynolds, Christine, et al.
Publicado: (2014)

Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas
por: Tran, Phuoc T., et al.
Publicado: (2008)

Bim plays apoptosis offense
por: Powell, Kendall
Publicado: (2007)

Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells
por: De Beule, Nathan, et al.
Publicado: (2017)

MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways
por: Saiki, Anne Y., et al.
Publicado: (2014)

Oncogenic KRAS activates an embryonic stem cell-like program in human colon cancer initiation
por: Le Rolle, Anne-France, et al.
Publicado: (2016)

Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy
por: Sandri, Sara, et al.
Publicado: (2017)

miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes
por: Qian, Li, et al.
Publicado: (2011)

Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer
por: Oran, Amanda R., et al.
Publicado: (2016)

Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects
por: Loupe, Jacob M., et al.
Publicado: (2016)

A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling
por: Matissek, Stephan J., et al.
Publicado: (2022)

BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations
por: Costa, Daniel B, et al.
Publicado: (2007)

Analysis of acquired mutations in transgenes arising in Ba/F3 transformation assays: findings and recommendations
por: Watanabe-Smith, Kevin, et al.
Publicado: (2017)

MEK Inhibitors Potentiate Dexamethasone Lethality in Acute Lymphoblastic Leukemia Cells through the Pro-apoptotic Molecule BIM
por: Rambal, Anila A., et al.
Publicado: (2009)

BIM mediates synergistic killing of B-cell acute lymphoblastic leukemia cells by BCL-2 and MEK inhibitors
por: Korfi, K, et al.
Publicado: (2016)

Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM
por: Matheson, Elizabeth C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_khvph38drqtam7hhsob65dv22o